skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: subject: Cardiovascular Disease remove subject: Clinical Medicine remove xxx: xxx remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
An Update on Inflammation in Atherosclerosis: How to Effectively Treat Residual Risk
An Update on Inflammation in Atherosclerosis: How to Effectively Treat Residual Risk
Material Type:
Article 		Add to My Research

An Update on Inflammation in Atherosclerosis: How to Effectively Treat Residual Risk

Clinical therapeutics, 2023-11, Vol.45 (11), p.1055-1059 [Peer Reviewed Journal]

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;2023. The Authors ;ISSN: 0149-2918 ;EISSN: 1879-114X ;DOI: 10.1016/j.clinthera.2023.08.016 ;PMID: 37716836

Full text available

Citations Cited by
2
Moderate-to-vigorous group aerobic exercise versus group leisure activities for mild-to-moderate depression in adolescents: study protocol for a multicentre randomised controlled trial
Moderate-to-vigorous group aerobic exercise versus group leisure activities for mild-to-moderate depression in adolescents: study protocol for a multicentre randomised controlled trial
Material Type:
Article 		Add to My Research

Moderate-to-vigorous group aerobic exercise versus group leisure activities for mild-to-moderate depression in adolescents: study protocol for a multicentre randomised controlled trial

BMJ open, 2022-07, Vol.12 (7), p.e060159-e060159 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2021-060159 ;PMID: 35820753

Full text available

Citations Cited by
3
HLA-DRB104/13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus
HLA-DRB104/13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus
Material Type:
Article 		Add to My Research

HLA-DRB104/13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus

Annals of the rheumatic diseases, 2013-06, Vol.72 (6), p.1018-1025 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Copyright: 2013 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2012-201760 ;PMID: 22893315 ;CODEN: ARDIAO

Full text available

Citations Cited by
4
Effects of SGLT2 Inhibitors on Atherosclerosis: Lessons from Cardiovascular Clinical Outcomes in Type 2 Diabetic Patients and Basic Researches
Effects of SGLT2 Inhibitors on Atherosclerosis: Lessons from Cardiovascular Clinical Outcomes in Type 2 Diabetic Patients and Basic Researches
Material Type:
Article 		Add to My Research

Effects of SGLT2 Inhibitors on Atherosclerosis: Lessons from Cardiovascular Clinical Outcomes in Type 2 Diabetic Patients and Basic Researches

Journal of clinical medicine, 2021-12, Vol.11 (1), p.137 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2077-0383 ;EISSN: 2077-0383 ;DOI: 10.3390/jcm11010137 ;PMID: 35011882

Full text available

Citations Cited by
5
A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus
A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus
Material Type:
Article 		Add to My Research

A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus

Annals of the rheumatic diseases, 2010-05, Vol.69 (5), p.834-840 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 INIST-CNRS ;Copyright: 2010 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2009.115535 ;PMID: 19762360 ;CODEN: ARDIAO

Full text available

Citations Cited by
6
Design and testing of a tool for evaluating the quality of diabetes consumer-information Web sites
Design and testing of a tool for evaluating the quality of diabetes consumer-information Web sites
Material Type:
Article 		Add to My Research

Design and testing of a tool for evaluating the quality of diabetes consumer-information Web sites

Journal of medical Internet research, 2003-11, Vol.5 (4), p.e30-e30 [Peer Reviewed Journal]

Copyright Gunther Eysenbach MD MPH, Associate Professor 2003 ;Joshua J Seidman, Donald Steinwachs, Haya R Rubin. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 27.11.2003. Except where otherwise noted, articles published in the Journal of Medical Internet Research are distributed under the terms of the Creative Commons Attribution License (http://www.creativecommons.org/licenses/by/2.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, including full bibliographic details and the URL (see "please cite as" above), and this statement is included. 2003 ;ISSN: 1438-8871 ;EISSN: 1438-8871 ;DOI: 10.2196/jmir.5.4.e30 ;PMID: 14713658

Full text available

Citations Cited by
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait